Barr Accused Of Jumping The Gun

WILMINGTON, DEL. (CN) - In an ironic complaint filed as Barr Pharmaceuticals settled an antitrust suit that accused it of taking $20 million from Warner Chilcott and promising not to compete by making a cheaper, generic form of Warner's Ovcon contraceptive, GlaxoSmithKline sued Barr in Federal Court, accusing it of seeking FDA approval to make a generic form the Glaxo's prostate drug, Avodart, before that drug's patent expires.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit